US 6214805
RNase L activators and antisense oligonucleotides effective to treat RSV infections
expired A61KA61K38/00A61K47/549
Quick answer
US patent 6214805 (RNase L activators and antisense oligonucleotides effective to treat RSV infections) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Apr 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61K47/549, A61P, A61P31/14